

(Alliance News) - Stocks in London ended higher on Wednesday as investors continued to track the war in Ukraine, while in the US, Netflix weighed on t...


(Alliance News) - The FTSE 100 index moved upwards with a bit more conviction as the morning progressed in London on Wednesday, shaking off a mixed US...


(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for...


(Sharecast News) - Oxford Biomedica reported a 63% improvement in total revenues in its preliminary results on Wednesday, to £142.8m, although it...


LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree


Oxford Biomedica affirms end to licensing deal with Sio Gene Therapies


(Sharecast News) - Oxford Biomedica's licensee for a Parkinson's disease treatment has pulled out of development and returned the rights to the UK com...